XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of CashFlows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net income (loss) $ (19,310,623) $ 11,387,890
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation and amortization 1,815,367
Change in right of use assets - related party 210,114
Change in right of use assets 997,027
Change in fair value of derivative liabilities (14,264,476) (300,885)
Change in derivative liability for authorized shares shortfall 162,275,278
Interest and amortization of debt discount 32,577,069 967,759
(Gain) loss on conversion of convertible notes payable 880
Gain on settlement of convertible notes payable and accrued interest, warrants and accounts payable and cancelation of common shares in exchange for Series Y preferred shares (4,854,139)
Gain on settlement of convertible notes payable and accrued interest and cancelation of common shares and warrants for cash (163,420) (170,085,696)
(Gain) on forgiveness of debt (192,521)
Payment of accrued rent due to related party
Share-based compensation 166,855
Changes in operating assets and liabilities:    
Payment of accrued rent due to related party (122,865)
Inventories (122,154)
Accrued payroll and related expenses 123,929
Accounts receivable (82,925)
Prepaid expenses (70,109) 50,000
Security deposits 2,437
Accounts payable and accrued expenses 58,462 49,992
Contract liabilities 73,000 25,000
Environmental remediation (22,207)
Change in lease liability (1,008,459)
Net cash generated by operating activities 566,238 (385,658)
Cash flows from investing activities:    
Purchases of property and equipment - related party (152,500)
Purchases of property and equipment (2,394,823)
Net cash used in investing activities (2,547,323)
Cash flows from financing activities:    
Proceeds from sale of Series X preferred shares 200,000
Proceeds from issuance of non-convertible notes payable 225,000 357,053
Repayment of a non-convertible note payable (162,039)
Proceeds from advances 14,311
Repayments of advances (9,930)
Cash paid in settlement of debt and warrants (176,000)
Net cash provided by (used in) financing activities 62,961 385,434
Net decrease in cash (1,918,124) (224)
Cash, beginning of period 2,958,293 1,485
Cash, end of period 1,040,169 1,261
Supplemental disclosures of cash flow information:    
Cash paid during period for interest 195,000 400
Cash paid during period for taxes
Supplemental disclosure of non-cash investing and financing activities:    
Series Y preferred shares issued as settlement for convertible notes payable, accrued interest and warrants 1,314,678
Reclassification of derivative liability to additional paid in capital due to elimination of authorized share shortfall 29,719,392
Increase in right of use assets and operating lease liabilities 2,677,544
Note proceeds for equipment purchases 590,000
Equipment purchases in accounts payable and accrued expenses 311,805
Issuance of common shares previously to be issued 8 3
Amortization of discount on preferred stock 34,798,923
Common shares issued upon conversion of convertible notes and accrued interest 133,002
Reclassify accrued interest to convertible notes payable 93,685
Reduction of derivative liabilities stemming from settlement of convertible notes payable, accrued interest and warrants in exchange for Series Y preferred shares 4,834,911
Reduction of derivative liabilities stemming from settlement of convertible notes payable, accrued interest and cancelation of common shares and warrants for cash $ 169,815,037